Insider filing
Traded Mar 9 · filed 1 day later
Gift or transfer — classified separately from trades.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Feb 11, 2026 · Filed Feb 12, 2026
The CEO of Encompass Health sold $9.92M of Encompass Health shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$9,923,082
Shares × reported transaction price
6 days after results of Feb 5, 2026, 78 days before results of Apr 30, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $113.43 on Feb 11, 2026, 21% above its 52-week low and 11% below its high, after a 5% rise over the previous 30 trading days
52-week range $93.68 (Mar 13, 2025) to $127.18 (Oct 27, 2025), 59% of the way up, from 251 adjusted closes. 30 trading days earlier: $107.96 on Dec 29, 2025. Describes the past only, not a forecast
RSI 74, 2% under its 200-day average, 8% above its 50-day average, 11% below the 52-week high, 20-day volatility 35% a year, against the S&P 500: +11 points over 1 month, −3 points over 3 months, −12 points over 6 months
From the adjusted closes up to Feb 11, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Traded 8 days before EHC filed an 8-K: changed a top executive or board member (Feb 19, 2026)
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.3% | +1.1% | −4.4% |
| 30 days | −7.9% | −1.9% | −6.0% |
| 90 days | −2.6% | +9.7% | −12.3% |
| 180 days | +13.3% | +13.3% | 0.0% |
Past results only. Not a forecast.
Insider filing
Traded Mar 9 · filed 1 day later
Gift or transfer — classified separately from trades.
Insider selling
First sale since 2016Traded Mar 9 · filed 1 day laterNot reported under a pre-arranged trading plan
Encompass Health's Sr. Vice Pres. and Treasurer sold $1.28M of Encompass Health shares. The filing does not indicate a pre-arranged trading plan.
Insider filing
Traded Feb 28 · filed 3 days later
Routine share withholding; mechanical by default.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.